XML 55 R44.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Based Compensation (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Mar. 31, 2021
Jun. 30, 2021
Jun. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Equity compensation expense   $ 24 $ (5)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value 200,239    
Stock appreciation rights granted, weighted average exercise price (per share)   $ 129.01  
Shares Granted To Non Employee Directors   8,154  
Document Period End Date   Jun. 30, 2021  
Options exercisable (shares)   1,633,693  
Options exercisable, weighted average price (per share)   $ 96.87  
Options, remaining term   4 years 4 months 24 days  
Compensation cost not yet recognized   $ 56  
Period for recognition   1 year  
Performance Shares [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   167,883  
Restricted Stock Units (RSUs) [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   327,813